Lansoprazole Teva Pharma (Lansoprazole)

Lansoprazole irreversibly inhibits the H⁺/K⁺‑ATPase (gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it provides prolonged suppression of gastric acidity, allowing damaged tissues to heal.

The appropriate dose of Lansoprazole Teva Pharma is determined by the prescribing healthcare professional based on the specific indication, severity of disease, patient age, renal and hepatic function, and any concomitant therapies.

Safety data for Lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the proton pump inhibitor (PPI) class, which provides more potent and longer‑lasting acid suppression than H₂‑receptor antagonists. Compared with other PPIs, its efficacy and safety profile are similar, though individual patient response and drug‑interaction potential may vary.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability.

Lansoprazole Teva Pharma is taken orally, usually as a whole tablet swallowed with a glass of water. It is commonly administered before a meal, most often in the morning, unless otherwise directed by the prescriber.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant electrolyte disturbances like hypomagnesemia, which can lead to cardiac arrhythmias or muscle cramps.

Patients with known hypersensitivity to lansoprazole or any component of the formulation should avoid its use. Caution is also advised for individuals with severe liver disease, those on medications that require an acidic environment for absorption, and patients with a history of C. difficile infection.